0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Nanotechnology-based strategies for treatment of ocular disease.

      Acta Pharmaceutica Sinica. B
      Elsevier BV
      Ocular disease, Therapy, Ocular drug delivery, Diagnosis, Nanosystems, Eye, Nanocarrier

      Read this article at

      ScienceOpenPublisherPMC
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Ocular diseases include various anterior and posterior segment diseases. Due to the unique anatomy and physiology of the eye, efficient ocular drug delivery is a great challenge to researchers and pharmacologists. Although there are conventional noninvasive and invasive treatments, such as eye drops, injections and implants, the current treatments either suffer from low bioavailability or severe adverse ocular effects. Alternatively, the emerging nanoscience and nanotechnology are playing an important role in the development of novel strategies for ocular disease therapy. Various active molecules have been designed to associate with nanocarriers to overcome ocular barriers and intimately interact with specific ocular tissues. In this review, we highlight the recent attempts of nanotechnology-based systems for imaging and treating ocular diseases, such as corneal d iseases, glaucoma, retina diseases, and choroid diseases. Although additional work remains, the progress described herein may pave the way to new, highly effective and important ocular nanomedicines.

          Related collections

          Author and article information

          Journal
          28540165
          5430571
          10.1016/j.apsb.2016.09.001

          Ocular disease,Therapy,Ocular drug delivery,Diagnosis,Nanosystems,Eye,Nanocarrier

          Comments

          Comment on this article

          scite_